You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2025

Drugs in MeSH Category Insecticides


✉ Email this page to a colleague

« Back to Dashboard


ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Exclusivity Expiration
Galderma Labs Lp SOOLANTRA ivermectin CREAM;TOPICAL 206255-001 Dec 19, 2014 AB RX Yes Yes 9,782,425 ⤷  Try for Free ⤷  Try for Free
Padagis Israel PERMETHRIN permethrin CREAM;TOPICAL 076369-001 Apr 21, 2003 AB RX No Yes ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
Zydus Lifesciences IVERMECTIN ivermectin CREAM;TOPICAL 215210-001 Aug 2, 2022 AB RX No No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Exclusivity Expiration
Showing 1 to 3 of 3 entries

Insecticides Market Analysis and Financial Projection

The global insecticides market is undergoing significant transformation, driven by technological innovation, regulatory shifts, and evolving agricultural needs. With projections showing the market reaching between $49.35 billion[7] and $148.51 billion[1] by 2030-2034 (depending on product segments), the industry faces both opportunities and challenges in intellectual property management and competitive dynamics.

Market Growth Drivers

Expanding Agricultural Demands:

  • Rapid urbanization and population growth have increased reliance on crop protection chemicals, with insecticide applications crucial for safeguarding 10-25% of global cereal yields threatened by pests[15].
  • The aerosol insecticides segment shows particularly strong growth (5.1% CAGR), driven by urban pest control needs and precision application technologies[1].

Technological Advancements:

  • Foliar application dominates with 56.9% market share due to enhanced delivery systems combining drones, GPS mapping, and smart spraying technologies[7].
  • Emerging bioinsecticides now account for 18% of R&D pipelines, reflecting a 34% increase in eco-friendly formulations since 2022[10][15].

Patent Landscape Dynamics

Key Innovations:

  • 2,371 biocontrol-related patents were filed between 1982-2021, with the US leading (694 patents) and peak activity in 2015 (278 filings)[4]. Major clusters focus on:
    • Microbial-based formulations (42% of patents)
    • Synergistic chemical-biological combinations (28%)
    • Precision delivery mechanisms (19%)[2]

Patent Expirations & Generics:

  • 19 active ingredients lose patent protection by 2028, including:
Compound Class Patent Holder Expiry Year
Chlorantraniliprole Insecticide FMC Corporation 2023[13]
Bixafen Fungicide Bayer 2023[13]
Sulfoxaflor Insecticide Corteva 2025[9]

This expiration wave could unlock $7.2 billion in generic production opportunities by 2030[13].

Regional IP Strategies

North America:
Maintains 38% patent dominance through SPC extensions adding 5+ years protection post-expiry[9]. Recent litigation (e.g., FMC vs. Natco Pharma over Chlorantraniliprole[5]) demonstrates aggressive IP enforcement.

Asia-Pacific:
India emerging as innovation hub with:

  • 140% increase in agrochemical patents since 2020
  • Novel Miticidal Benzyalamide patents securing 20-year protections[12]
  • 63% of R&D targeting climate-resilient formulations[15]

Regulatory & Environmental Pressures

  • EU's FARM program aims to reduce chemical usage 40% by 2027 through $120M investments in biocontrol alternatives[15].
  • Neonicotinoid restrictions now impact 78 countries, accelerating reformulation patents (e.g., Insecticides India's Plant Growth Regulator-insecticide hybrids[15]).

"The coming patent cliff creates both disruption and opportunity - generics could reduce farmer costs by 30-60%, but require $2.8B+ in formulation R&D to meet evolving regulations." - S&P Global Agribusiness Report[9]

This complex landscape positions companies that integrate IP strategy with sustainable innovation for leadership, particularly in developing hybrid chemical-biological solutions and precision application systems. Success increasingly depends on navigating the $1.2B/year patent litigation environment while meeting COP28 agricultural emissions targets through cleaner chemistries[7][15].

References

  1. https://farmonaut.com/news/revolutionizing-pest-control-aerosol-insecticides-market-set-to-skyrocket-to-148-51-billion-by-2034/
  2. https://www.eurekaselect.com/article/126047
  3. https://www.ncbi.nlm.nih.gov/mesh/68008724
  4. https://pubmed.ncbi.nlm.nih.gov/36173076/
  5. https://timesofindia.indiatimes.com/business/india-business/hc-restrains-natco-pharma-from-manufacturing-using-insecticides-with-fmc-corporations-patent/articleshow/84753054.cms
  6. https://www.ifpma.org/wp-content/uploads/2023/01/i2023_The-Globalisation-of-the-Pharmaceutical-Industry-Monograph.pdf
  7. https://www.mordorintelligence.com/industry-reports/global-insecticides-market-industry
  8. https://ipfdalaw.com/patent-regulatory-legal-issues-related-to-fertilizers-fungicides-pesticides-bulk-chemicals/
  9. https://www.spglobal.com/commodity-insights/en/research-analytics/new-generics-update-2022-agribusiness-report
  10. https://www.prnewswire.com/news-releases/insecticides-market-to-reach-usd-12-4-billion-by-2030--growing-at-a-4-80-cagr--credence-research-302404803.html
  11. https://www.pnas.org/doi/10.1073/pnas.1013020107
  12. https://timesofindia.indiatimes.com/insecticides-india-gets-patents-for-two-novel-agrochemical-compounds-for-20-yrs/articleshow/91592570.cms
  13. https://www.agribusinessglobal.com/agrochemicals/active-ingredients-coming-off-patent-in-crop-protection-market/
  14. https://patents.google.com/patent/WO2012095533A1/en
  15. https://www.kingsresearch.com/insecticides-market-1155

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.